Chemoinformaics analysis of 2-[(1R,2S,3S)-3-HYDROXY-2-[(Z)-PENT-2-ENYL]CYCLOPENTYL]ACETIC ACID
| Molecular Weight | 212.289 | nRot | 5 |
| Heavy Atom Molecular Weight | 192.129 | nRig | 1 |
| Exact Molecular Weight | 212.141 | nRing | 1 |
| Solubility: LogS | -5.18 | nHRing | 0 |
| Solubility: LogP | 5.455 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 35.7819 |
| nHD | 2 | BPOL | 20.9321 |
| QED | 0.332 |
| Synth | 1.894 |
| Natural Product Likeliness | 0.924 |
| NR-PPAR-gamma | 0.538 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.015 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.725 |
| MDCK | 0.0000153 |
| BBB | 0.971 |
| PPB | 0.870371 |
| VDSS | 2.906 |
| FU | 0.0384506 |
| CYP1A2-inh | 0.51 |
| CYP1A2-sub | 0.212 |
| CYP2c19-inh | 0.453 |
| CYP2c19-sub | 0.071 |
| CYP2c9-inh | 0.218 |
| CYP2c9-sub | 0.918 |
| CYP2d6-inh | 0.184 |
| CYP2d6-sub | 0.134 |
| CYP3a4-inh | 0.228 |
| CYP3a4-sub | 0.059 |
| CL | 3.76 |
| T12 | 0.211 |
| hERG | 0.311 |
| Ames | 0.03 |
| ROA | 0.023 |
| SkinSen | 0.973 |
| Carcinogencity | 0.173 |
| EI | 0.96 |
| Respiratory | 0.965 |
| NR-Aromatase | 0.1 |
| Antiviral | Yes |
| Prediction | 0.60222 |